Tirzepatide 20mg Peptide

Tirzepatide 20 mg is a highly pure research peptide in its lyophilized form. Tirzepatide is well-known to the scientific community as a dual agonist of the GIP and GLP-1 receptors, thus making this peptide an important component for scientists engaged in incretin signaling, receptor interactions, and metabolic processes studies.
Every vial of Tirzepatide includes 20 mg of the peptide substance.

Tirzepatide 20mg – Dual Agonist Research Peptide

The compound is referred to in the scientific literature as LY3298176; it is a man-made peptide with 39 amino acid residues. The design of Tirzepatide is largely modeled on the natural sequence of GIP but includes changes that allow it to act on GIP and GLP-1 receptors.
This multi-receptor property makes it distinct from other experimental drugs that are targeted toward GLP-1 receptors. The 20mg vial offers scientists an adequate amount for experimental studies.
Published chemical databases identify Tirzepatide as having a molecular weight of approximately 4,813 g/mol and the CAS Registry Number 2023788-19-2.

Understanding Tirzepatide’s Dual Receptor Activity

One of the principal characteristics of Tirzepatide is its ability to interact with two incretin receptor pathways simultaneously.
The GIP receptor, or glucose-dependent insulinotropic polypeptide receptor, is involved in a range of biological signalling processes and is an established subject of metabolic research.
The GLP-1 receptor, or glucagon-like peptide-1 receptor, represents another extensively investigated incretin pathway.
Structural studies have demonstrated how Tirzepatide interacts with both GIPR and GLP-1R, giving researchers an opportunity to examine dual-receptor signalling within controlled experimental models.

Why Choose Tirzepatide 20mg?

The 20mg format provides a larger research quantity than lower-strength vials while remaining convenient for laboratory handling and experimental planning.
For research programmes involving repeated analytical procedures, having additional material from the same batch can help laboratories maintain consistency throughout an investigation. It may also reduce the need to introduce separate vials or different batches during related experimental work.
The appropriate quantity should always be selected according to the requirements of the individual research protocol.

99%+ Purity & Batch Documentation

Purity and traceability are important considerations when selecting peptides for laboratory investigation. Tirzepatide 20mg is specified at 99%+ purity, providing researchers with clearly identified material for analytical applications.
Where supplied, the Certificate of Analysis (COA) should be reviewed for information associated with the specific production batch. Researchers should retain batch numbers and relevant analytical documentation as part of their normal laboratory records.